Innovating to improve health worldwide

IFPMA-INTERFARMA-FIFARMA statement on the Rio de Janeiro Declaration of the G20 Health Ministers

The innovative pharmaceutical industry, represented by IFPMA, INTERFARMA and FIFARMA reiterates its commitment to the G20 health priorities, reaffirmed in the Rio de Janeiro Declaration.

Twelfth meeting of the Intergovernmental Negotiating Body (INB)

On 4 November 2024 in Geneva, IFPMA delivered a statement at the twelfth meeting of the Intergovernmental Negotiating Body (INB).

Conclusion of COP16 Negotiations on Multilateral Mechanism for Benefit-Sharing of DSI

On the conclusion of the COP16 negotiations on proposals to include digital sequence information (DSI) within the scope of the Convention of Biodiversity (CBD), IFPMA delivered a Statement

74th WHO Regional Committee for Europe: Harnessing innovation for public health in the WHO European Region 2025-2030

On 31 October 2024 in Copenhagen, Denmark, IFPMA delivered a statement at the 74th WHO Regional Committee for Europe on harnessing innovation for public health in the WHO European Region 2025-2030.